对于神经疾病的RNA疗法
1Department of Molecular Genetics and Microbiology, Center for NeuroGenetics, University of Florida, Cancer Genetics Research Complex (CGRC), Gainesville, FL, United States.
Progress in molecular biology and translational science
|February 15, 2024
概括
神经系统疾病影响基本的生活技能,是导致残疾的主要原因. RNA疗法为治疗这些疾病提供了一个有希望的新途径,解决了对有效干预的迫切需要.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 生物技术是生物技术.
背景情况:
- 神经系统疾病显著影响日常生活技能,是全球死亡和残疾的主要原因.
- 世界卫生组织承认神经系统疾病,包括痴呆症,是主要的公共卫生危机.
- 目前的研究重点是了解疾病遗传学和分子机制,以开发新的治疗方法.
研究的目的:
- 讨论神经系统疾病的遗传学和机制.
- 探索基于RNA的分子在开发神经疾病治疗药物的应用.
- 审查RNA治疗在神经学中的挑战和未来前景.
主要方法:
- 审查关于神经系统疾病遗传学和分子机制的当前研究.
- 分析RNA疗法发展的进展.
- 讨论基于RNA的治疗方法的挑战和未来方向.
主要成果:
- 神经系统疾病是影响中枢神经系统的复杂疾病,导致各种功能障碍.
- 由于RNA分子开发的近期进展,RNA疗法呈现出越来越多的兴趣领域.
- 这篇文章概述了基于RNA的分子是如何被用于治疗干预的.
结论:
- 对神经系统疾病的有效治疗方法有着显著且日益增长的需求.
- RNA疗法在治疗一系列神经疾病方面具有相当大的前景.
- 对RNA疗法的持续研究和开发对于应对这一公共卫生挑战至关重要.
相关概念视频
Alzheimer's Disease: Treatment
189
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
189
Parkinson's Disease: Overview
546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Neurochemical Transmission: Sites of Drug Action
2.3K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.3K
Enzyme-linked Receptors
78.4K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.4K


